Skip to main content
Premium Trial:

Request an Annual Quote

NCI Taps RemedyMD to Provide Research Management Software for NCI Projects

Premium

Researchers at the National Cancer Institute will use RemedyMD's Investigate Integrated Research Management System software to manage and analyze large quantities of cancer research data generated in nine laboratories in NCI's Advanced Technology Program and Patient Characterization Center, according to a statement issued this week.

NCI subcontractor SAIC-Frederick signed an agreement with Sandy, Utah-based RemedyMD to implement the system under the auspices of NCI's Advanced Technology Partnerships Initiative.

Built on RemedyMD's Mosaic platform, the Investigate software integrates a laboratory information management system and electronic laboratory notebook to help researchers collect, aggregate, harmonize, and analyze their data.

The tool provides resources for experiment design and execution, structured and unstructured data management, and biospecimen management. It also includes a web-enabled user-interface; data storage; and interface, querying, and reporting tools.

Under the terms of the agreement, RemedyMD and SAIC will work on improving laboratory workflows, biospecimen management approaches, instrument integration, data visualization, and developing a research project review and approval system that will support research efforts.

These improvements to the system are expected to result in "powerful new approaches" that could yield "important insights into genomic, proteomic, and imaging studies," Bruce Crise, business development director at SAIC, said in a statement.

NCI's Advanced Technology Partnerships Initiative aims to speed the translation of research discoveries into new treatments for patients with cancer and AIDS by forming partnerships with academic research institutions, life sciences companies, and nonprofit organizations.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.